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Fatty acid (FA) metabolism is an integral part of myocardial cellular
metabolism and has been studied in normal, ischemic, post-ischemic, and
hibernating myocardium with Positron Emission Tomography and carbon-14
methods. These tracer studies generally follow only the saturated (S) FA,
palmitate. Human plasma contains a mixture of unsaturated (unS) and SFAs
in a 1.3: 1 ratio. It remains unclear if the oxidation of palmitate is representa-
tive of a biological mixture of FAs. The purpose of this study was to determine
if oxidation of SFAs or unSFAs is similar to a biological mixture.
Methods: Working rat hearts were supplied with carbon-13 enriched lac-
tate (8 mM) in addition to FA (0.27 mM) as either SFA, unSFA or a biologi-
cal mixture. The FAs studied (palmitic[16:0I, palmitoleic[16:1). stearic[18:0],
0Ieic[18:1). Iinoleic[18:2)) constitute >85% of the FAs found in plasma.
The mixture consisted of all 5 FAs in their relative proportions in human
plasma. Carbon-13 Magnetic Resonance Spectroscopy and isotopomer anal-
ysis were used to determine the contribution of each substrate to the acetyl-
CoA pool. The results were analyzed using ANOVA and Student-Newman-
Keuls tests.
Results: The type of FA used did not significantly alter CO or RPP The
oxidation of unSFAs was significantly less than the oxidation of SFAs or the
biological mixture of FAs.
*p < 005
Conclusions: Under these conditions saturated FAs are preferred for oxi-
dation compared to unsaturated FAs. The oxidation of palmitate or stearate
appears representative of a biological mixture
The recent findings that lipid lowering therapy reduces clinical events to a
Jbrg Kreuzer, Jbrg Bader, Stefanie Denger, Kai Ritter, Lothar Jahn,
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Monocyte migration into the vessel wall is an early step in atherogenesis.
A number of chemotactic factors for monocytes have been identified, The
regulation of the chemotactic response, however, is only poorly understood.
We studied the influence of low density lipoprotein (LDL) on chemotactic
mobility to a standardized stimulus, Migration of human monocytoid U937
cells was abolished by 30 h incubation in medium with 10% Iipoprotein-
deficient-serum. Human LDL, VLDL. HDL. or free cholesterol (5-20 j.Lg/mll
were added for 0.5-12 h. At the end of each incubation period, chemotaxis
to 1% human serum (modified Boyden chamber). viability (dye exclusion),
and cellular cholesterol content (high performance thin layer chromatogra-
phy) were measured. In the same experimental setting the effects of the
pharmacological agents chloroquine (60 j.LMl. indomethacin (20 j.Lg/ml). or
acetylsalicylic acid (ASS, 100 j.LM) on LDL mediated chemotaxis were stud-
ied. In some experiments the effect of fatty acids (linoleic acid, arachidonic
acid, 10 j.LM for 2 hours) on restoration of chemotaxis was investigated.
Chemotaxis was restored by LDL in a time and dose dependent manner
starting at concentrations as low as 5 j.Lg/ml and incubation periods of 30
minutes. Free cholesterol, VLDL, or HDL had no such effect on chemotaxis.
Viability and total cholesterol was not different in all groups. Simultaneous
incubation of cells with chloroquine, indomethacin or ASS reduced restitu-
tion of chemotaxis by LDL by 71 %, 82% or 68% respectively. In contrast.
the agents had only slight inhibitory effects on chemotactic mobility of con-
trol cells which were serum fed. Incubation with linoleic acid showed 60%
restoration of chemotaxis, whereas arachidonic acid stimulated chemotaxis
response to 140% of positive control.
Conclusion: The data are consistent with a novel cyclooxygenase depen-
dent regulation of chemotaxis by LDL.
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Recombinant Endotoxin-binding Protein (rBPI23)
Attenuates Endotoxin-induced Circulatory
Changes in Humans
Lipoprotein(a) Assayed from Frozen Serum
Degrades with Time in Storage
Tilt CPT AN PE Tilt
ILl.SBPI ILl.SBP) (Slope) (Slope) (Ll.NE)
1 OH-BRD -63 ± 21* 22 ± 9* 0.0 ± 06*t 0.4 ± 1't 154±216
2.0H-NBR -36 ± 11 t 34 ± 10 3.8 ± 24 8.8 ± 3 284 ± 170
3. NL-NBR -6± 8 29 ± 15 4.2 ± 29 7.5 ± 7 246 ± 189
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The protective effect of rBPI 23 on the circulatory changes induced byexperi-
mental endotoxemia in humans was tested in a controlled blinded crossover
study. Eight healthy male volunteers were challenged twice with an intra-
venous bolus injection of endotoxin (40 EUlkgl and concurrently received ei-
ther rBPI 23 (1 mg/kg) or placebo. Hemodynamic parameters were obtained
non-invasively over a period of twelve hours by means of M-mode-, Two-
dimensional- and Doppler Echocardiography. Blood Pressure was recorded
using a Dynamap. rBPln significantly reduced endotoxin-induced increase
in Heartrate (85 ± 5 versus 67 ± 5 Beat/min, P = 00078). Cardiac Index
(3.98 ± 0.25 versus 3.28 ± 0.27 Llmin/m2, P = 00156). and Maximal Ve-
locity in the Left Ventricular Outflow Tract (1.26 ± 0.07 versus 1.09 ± 0.05
m/sec, P < 0.05). rBPI23 diminished the endotoxin-induced decrease in Sys-
temic Vascular Resistance (1633 ± 79 versus 2051 ± 134 dyne*sec/cm-5, P
= 0.0304). rBPI23 did not prevent the endotoxin-induced rise in Body Tem-
perature (+ 1.9°C) and Systolic, Diastolic and Mean Arterial Blood Pressure
were comparable in the rBP123- and placebo-treatment arm. Both treatment
periods showed a small reduction in End-SystOlic and End-Diastolic Volumes
as measured by M-mode. Circulatory changes induced by endotoxin lasted
for 12 hours, The protective effect of rBPI23 was maximal between 1:30 and
4:00 hours after the start of the endotoxin infusion.
Conclusion: These results indicate that rBPI23 is capable of attenuating
the circulatory effects of endotoxin in humans.
Sarah M. Vernon, Ian J. Sarembock, Carlos R. Ayers, Eric R. Powers, Lawrence
W Gimple. University of Virginia, Charlottesville, VA
Although we have previously identified a strong correlation between lipopro-
tein(a) (Lp(a)) concentrations measured from fresh serum and restenosis af-
ter balloon angioplasty (PTCA), the relationship between Lp(al and resteno-
sis remains controversial. In previous studies reporting a lack of corre-
lation between Lp(a) concentration and restenosis, serum samples were
frozen for prolonged periods prior to assay, and the reported concentra-
tions of Lp(a) were lower than in studies reporting a positive correlation
between Lp(al and restenosis, We hypothesized that this may be due to
degradation of Lp(a) occurring during storage. Accordingly, we measured
Lp(a) concentrations (monoclonal/polyclonal sandwich enzyme immunoas-
say, MACRA Lp(a)) from serum samples of patients undergoing PTCA Re-
peated freeze/thaw cycles (_70°) without storage did not result in Lp(al
degradation. In group 1 patients (n = 10), mean Lp(a) concentrations de-
creased significantly after 18 months of storage at _70° (30 ± 24 vs 6.8
± 6.8, P = 0.007). In group 2 patients (n = 6), serum samples previously
frozen and stored for 18 months demonstrated continued degradation after
a subsequent 9 months of storage (48 ± 19 vs 33 ± 15, P = 0.00021. In con-
clusion, we observed that Lp(a) degrades significantly during storage, even
when samples remain frozen at _70°. This observation may explain inconsis-
tencies in results of previously published studies examining the relationship
between Lp(a) and restenosis, and casts doubt upon studies measuring Lp(a)
concentrations from stored samples.
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Conclusions: (1) Patients with idiopathic BRD present with OH, have at-
tenuated response to CPT and normal catecholamine response to tilt. (2)
OH-BRD and BRF are two different syndromes with different etiologies and
clinical manifestations; however, both have BR abnormalities.
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Fibrinogen and Lp(a) in Ischemic Heart Disease.
The Quebec Cardiovascular Study
Regulation of Glucose Utilization by L-Carnitine
in Cardiac Myocytes
Salah Abdel-aleem, Mohamed Sayed-Ahmed, Steven Hendrickson, James SI.
louis, Mark P. Anstadt, James E. lowe. Duke University Medical Center, Durham,
North Carolina, 27710
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Values are presented as the mean ± SD of at least three different exper-
iments. Asterisks represent a p < 0.05 of the effect of carnitine vs control.
These data show that L-carnitine stimulates PDH activity by 50%. However,
the flux of acetyl-CoA and glucose through Kreb's cycle was significantly de-
creased by this compound. These results suggest that L-carnitine enhances
the removal of acetyl-CoA produced from glucose metabolism out of the
mitochondrial matrix, thereby, activating the PDH complex.
L-Carnitine has been shown to protect the myocardium from ischemic in-
jury, and also improves cardiac function in cardiomyopathies associated with
carnitine deficiency and diabetes. However, the exact mechanism whereby
carnitine exerts its effect is not fully understood. The present study was de-
signed to investigate the effect of carnitine on the regulation of glucose uti-
lization in the heart. These studies were performed bl determining the effect
of L-carnitine (5 mM) on the 14C02 release from [1 J C]pyruvate (an index of
pyruvate dehydrogenase complex, PDH), [2-14C]pyruvate (an index of acetyl-
CoA flux through Kreb's cycle). and [6_14C]glucose (an index of the oxidative
utilization of glucose). in rat myocytes.
Bernard Cantin, Sital Moorjani, Jean-Pierre Despres, Paul-J. Lupien, Gilles
R. Dagena is. Upid Research Center, !..Eval University. Quebec, Canada; Department of
Medicine, University ofMontreal, Montreal, Canada
In an ongoing ischemic heart disease (IHD) risk factor study, plasma lipid,
Lp(a) and fibrinogen measurements were performed in 2125 men aged 45-
75 years in 1985. The subjects were followed until September 1st 1990. Dur-
ing that period, 116 first IHD events were documented (myocardial infarction,
angina and IHD death). Subjects with IHD were older (59 ± 8 vs 56 ± 7 years;
p < 0.0011. had higher systolic pressure (137 ± 17 vs 130 ± 17 mmHg; p <
0.001). a higher frequency of smoking ~20 cig/d (32 vs 23%; p = 0.027) and
a higher prevalence of diabetes (16 vs 4%; p < 0.001). Total cholesterol (235
± 41 vs 221 ± 39 mg/dL; p < 0.001), LDL-cholesterol (162 ± 37 vs 149 ± 35
mg/dL; p < 0.001), Lp{a) (41.0 ± 45.9 vs 32.7 ± 34.9 mg/dL; p = 0.014) and
fibrinogen (3.89 ± 0.81 vs 3.55 ± 0.75 gil; p < 0.001) levels were higher in
IHD while HDL-cholesterol was lower (37 ± 9 vs 40 ± 10 mg/dL; p ~ 0.005).
Adjusted risk ratios were significantly increased in the third fibrinogen terti Ie
(2.4 ± 0.3; p < 0.001) but not in the second fibrinogen nor in any Lp(a) tertile.
In order to further ascertain the role of fibrinogen and Lp(al. subjects were
assigned to one of four groups according to fibrinogen and Lp(a) levels. The
cutoff point for fibrinogen was the median of the distribution (3.52 gil) and
25 mg/dl for Lp(a).
Group 1: fibrinogen <3.52 gil and Lp(a) <25 mg/dL;
Group 2: fibrinogen <3.52 gil and Lp(a) ~25 mg/dL;
Group 3: fibrinogen ~3.52 gil and Lp(a) <25 mg/dL;
Group 4: fibrinogen ~3.52 gil and Lp(a) ~25 mg/dL.
on polyacrylamide (PAGE; 5 to 16% gradient) and agarose gel electrophore-
sis (0.8% in Tris-HCL buffer). No significant increase was observed in the
basal concentration of MDA between LDL from H and controls (0.8 ± 0.12
and 0.9 ± 0.15 nmoles of MDAlmg of protein, respectively). Instead, afteroxi-
dation MDA was 35.1 ± 4.5* nmoles/mg of protein LDL from H, and 23.5±4.1
in controls (*p < 0.05). PAGE confirmed the purity of LDL. present as an intact
apolipoprotein B100(apo-B 100 ). When oxidized LDL was run on PAGE an ex-
tensive apo-B100 fragmentation, replaced by lower fragments ranging from
97.400 to 205.000 m.w., was only observed in LDL from H but not in controls
in our experimental conditions. MDA content after oxidation of LDL corre-
lated well with the loss of intact apo-B 100. Finally, the relative LDL mobility
on agarose gel was evaluated. This assay allows to detect changes in elec-
tric charge induced by oxidation. Basal LDL from H and controls migrated as
homogeneous bands to 1.2 + 0.2 and 1.1 ± 0.2 cm from the origin. In con-
trast, oxidized LDL from H migrated to 2.1 ± 0.3* cm from the origin while
those of controls migrated to 1.5 ± 0.2 (*p < 0.05). Thus, in FH LDL appear
to be more susceptible to oxidationin vitro; the indices for LDL oxidizability
were all significantly different from those of controls. This phenomenon may
be an important additional mechanism of atherogenesis in homozigous FH.
<0.0001
<0.0001
*p-value>130
795
303 ± 55
23 ± 16
100-129
653
297 ± 57
22 ± 17
389
287 ± 59
21 ± 18
70-99<70
41
264 ± 54
14± 9
Decreased Resistance Against Oxidation of LDL
from Patients with Homozigous Familial
Hypercholesterolemia
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In Vitro Inhibition of Smooth Muscle Cell
Proliferation by Sterol 27-Hydroxylase
Metabolites
B.M. Steinberg, E.A. Grossi, J. Greenberg, C. Bizekis, w.J. O'Connor, A. Reiss,
A.C. Galloway, N.B. Javitt. New York University Medical Center, New York, NY
These findings were similar in men and women. Multivariate adjustment
for age, gender, body mass index, diabetes, smoking, alcohol intake, and use
of antihypertensive medication did not alter the results.
Conclusion: Decreasing LDL-C levels are associated with decreasing lev-
els of hemostatic risk factors. These findings support the hypothesis that
lipid lowering therapy may reduce clinical events by reducing thrombotic
tendency.
greater degree than it reduces stenosis severity suggest beneficial effects
other than plaque regression. To determine if a favorable lipid profile is asso-
ciated with decreased thrombotic tendency, we determined the relationship
between two hemostatic risk factors, fibrinogen and plasminogen activator
inhibitor (PAI-l), and LDL cholesterol (LDL-C) in 1,878 subjects free of cardio-
vascular disease in the Framingham Offspring Study. The subjects studied
ranged from those with hypobetalipoproteinemia, a condition characterized
by LDL-C :s 70 mg/dl, and a low incidence of thrombosis and coronary heart
disease, to other LDL-C levels grouped by NCEP guidelines.
Claudio Napoli, Alfredo Postiglione 1, Giuseppe Palumbo 2, Antonio Ruocco 1,
Giuseppe Ambrosio, Mario Condorelli, Mario Mancini 1, Massimo Chiariello. Div
of Cardiology. "Federico II" School of Medicine, University ofNaples, Italy; 1 Inst of
Internal Medicine and Metabolic Diseases, "Federico II" School of Medicine, University
of Naples, Italy; 2 Dept. of Molecular Pathology. "Federico II" School of Medicine,
University ofNaples, Italy
Familial hypercholesterolemia (FH) was the first genetic disorder recognized
to cause myocardial infarction. Homozigotes (H) inherit two mutant genes
at the low density lipoprotein (LDL) receptor locus, and as a result of the
increased levels and prolonged residence time of LDL in plasma, there is
a strong tendency toward accumulation of LDL in the arterial wall, causing
early atherogenesis. It has been shown that LDL might undergo oxidation be-
fore it can be taken up by macrophages and it become foam cells. Thus, one
additional explanation for atherogenesis in FH may be the extent to which
LDL is susceptible to oxidation. We selected 8 homozigous FH pts (mean
total-cholesterol 825 ± 70 mg/dl) matched with 8 healthy subjects to inves-
tigate the LDL oxidizability. Skin fibroblast cultures showed that one patient
was receptor negative, while others were receptor-defective. LDL were iso-
lated from serum by ultracentrifugations in KBr. Purified LDL was exposed to
oxygen radicals generated by the xanthine/xanthine oxidase reaction (2 mM
and 100 mU, respectively for 18 hs at 37' C). Malonildihaldehyde (MDAI con-
tent was evaluated by the thiobarbiturate method. LDL analysis was carried
Sterol 27-hydroxylase controls side chain oxidation of bile acids and is
found in vascular endothelial cells. Two metabolites of this oxidation are 27-
hydroxycholesterol (27-0H). which inhibits smooth muscle cell (SMC) pro-
liferation in vivo, and 3p-hydroxy-5-cholestenoic acid (C27). We quantified
the inhibitory capacity of both these compounds in vitro using a rabbit aor-
tic SMC preparation. Early passage SMC were grown to confluence, plated
at a density of 5,000 cells/well, and synchronized for 24 hrs. The cells were
then grown in the presence of Dulbecco's modified Eagle's medium with 5%
delipidated fetal calf serum alone (control). in increasing concentrations (1 0,
20,30 ,.,M) of 27-0H and C27 dissolved in 2-hydroxypropyl-p-cyclodextrin
(HPBCD). in an equivalent amount of HPBCD alone (control), and in colchicine
(1 mg/dl). Cell proliferation at 24 hrs was measured via formazans formation
from the tetrazolium salt MTS by absorbance at OD 490 nm There was no
significant difference in absorbance between the control and the HPBCD (ab-
sorbance 0.402 ± 0,037 vs 0.400 ± 0.057) or 10 ,.,M concentration 27-0H
(0.383 ± 0.0561 or C27 (0.374 ± 0.022) groups. However, concentrations of
20 and 30 ,.,M of 27-0H produced a significant growth inhibition (0.362 ±
0.030 and 0.350 ± 0.021, P < 0.01) compared to controls, as did C27 at 20
and 30 ,.,M (0.357 ± 0.22 and 0.344 ± 0.28, P < 0.01), while the colchicine
group exhibit the greatest inhibition (0.125 ± 0021). Thus 27-0H and C27
demonstrated a dose response growth inhibition of SMC, and endothelial
sterol 27-hydroxylase may play an important role in modulation of myointi-
mal hyperplasia during the atherosclerotic process.
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